Drugmaker will manufacture and distribute vaccine if human trials are successful Coronavirus - latest updates See all our coronavirus coverage AstraZeneca, the Cambridge-based pharmaceutical group, is teaming up with Oxford University to manufacture and distribute a coronavirus vaccine if clinical trials currently under way show it is effective. News of the partnership boosted AstraZeneca's share price, helping it to become Britain's most valuable company by market capitalisation.
AstraZeneca partners with Oxford University to produce Covid-19 vaccine
The Guardian - 30 Apr 2020 18:50
Drugmaker will manufacture and distribute vaccine if human trials are successful Coronavirus - latest updates See all our coronavirus coverage AstraZeneca, the Cambridge-based pharmaceutical group, is teaming up with Oxford University to manufacture and distribute a coronavirus vaccine if clinical trials currently under way show it is effective. News of the partnership boosted AstraZeneca's share price, helping it to become Britain's most valuable company by market capitalisation.
Share this Article
Recommended